Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polly Clayden

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in HIV and AIDS|April 21, 2017
Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feedingAmy L Slogrove, Polly Clayden, Elaine J Abrams
Current Opinion in HIV and AIDS|May 25, 2017
The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimenWillem D F Venter, Polly Clayden, Celicia Serenata, et al.
Journal of Virus Eradication|April 24, 2018
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic reviewAndrew Hill, Polly Clayden, Claire Thorne, et al.
Current Opinion in HIV and AIDS|April 15, 2017
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think TankMarco Vitoria, Nathan Ford, Polly Clayden, et al.
Journal of Virus Eradication|May 15, 2020
Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemicToby Pepperrell, Andrew Hill, Michelle Moorhouse, et al.
AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.
AIDS (London, England)|December 1, 2021
Impact of long-acting therapies on the global HIV epidemicNomathemba C Chandiwana, Celicia M Serenata, Andrew Owen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2019
Analysis of Pharmacovigilance Databases for Dolutegravir Safety in PregnancyNikolien S van De Ven, Anton L Pozniak, Jacob A Levi, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
AIDS (London, England)|December 1, 2021
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?W D Francois Venter, Celicia Serenata, Marco Vitoria, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in HIV and AIDS|April 21, 2017
Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feedingAmy L Slogrove, Polly Clayden, Elaine J Abrams
Current Opinion in HIV and AIDS|May 25, 2017
The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimenWillem D F Venter, Polly Clayden, Celicia Serenata, et al.
Journal of Virus Eradication|April 24, 2018
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic reviewAndrew Hill, Polly Clayden, Claire Thorne, et al.
Current Opinion in HIV and AIDS|April 15, 2017
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think TankMarco Vitoria, Nathan Ford, Polly Clayden, et al.
Journal of Virus Eradication|May 15, 2020
Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemicToby Pepperrell, Andrew Hill, Michelle Moorhouse, et al.
AIDS (London, England)|May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?Marco Vitoria, Andrew Hill, Nathan Ford, et al.
AIDS (London, England)|December 1, 2021
Impact of long-acting therapies on the global HIV epidemicNomathemba C Chandiwana, Celicia M Serenata, Andrew Owen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2019
Analysis of Pharmacovigilance Databases for Dolutegravir Safety in PregnancyNikolien S van De Ven, Anton L Pozniak, Jacob A Levi, et al.
Journal of the International AIDS Society|September 27, 2012
Preferred antiretroviral drugs for the next decade of scale upIsabelle Andrieux-Meyer, Alexandra Calmy, Pedro Cahn, et al.
AIDS (London, England)|December 1, 2021
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?W D Francois Venter, Celicia Serenata, Marco Vitoria, et al.
Pageof 3